Burton Needles

719 total citations
17 papers, 544 citations indexed

About

Burton Needles is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Burton Needles has authored 17 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Burton Needles's work include Bladder and Urothelial Cancer Treatments (4 papers), Urinary and Genital Oncology Studies (3 papers) and Brain Metastases and Treatment (2 papers). Burton Needles is often cited by papers focused on Bladder and Urothelial Cancer Treatments (4 papers), Urinary and Genital Oncology Studies (3 papers) and Brain Metastases and Treatment (2 papers). Burton Needles collaborates with scholars based in United States, United Kingdom and Netherlands. Burton Needles's co-authors include Alan Yagoda, Ezra E.W. Cohen, Victoria Villaflor, Kenneth J. Nichols, Tanguy Y. Seiwert, S. Percy Ivy, Everett E. Vokes, James L. Wade, Stuart J. Wong and Roy E. Smith and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Burton Needles

16 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Burton Needles United States 10 330 151 116 104 57 17 544
B. Dijkstra Ireland 13 173 0.5× 127 0.8× 53 0.5× 81 0.8× 26 0.5× 23 437
Arzu Yaren Türkiye 14 283 0.9× 58 0.4× 43 0.4× 138 1.3× 25 0.4× 51 550
CC Yau China 11 474 1.4× 357 2.4× 87 0.8× 180 1.7× 47 0.8× 30 980
Vincenzo De Lisi Italy 17 682 2.1× 125 0.8× 76 0.7× 220 2.1× 36 0.6× 44 902
Shane Y. Morita United States 9 231 0.7× 151 1.0× 42 0.4× 84 0.8× 18 0.3× 22 503
Anne Cowppli‐Bony France 12 159 0.5× 65 0.4× 25 0.2× 106 1.0× 27 0.5× 17 351
D D’Amico Italy 8 158 0.5× 156 1.0× 23 0.2× 95 0.9× 12 0.2× 17 433
Toshiharu Kanai Japan 11 157 0.5× 265 1.8× 343 3.0× 45 0.4× 26 0.5× 31 589
Raza A. Dilawari United States 11 320 1.0× 172 1.1× 15 0.1× 126 1.2× 45 0.8× 14 522
R S Prichard Ireland 13 245 0.7× 243 1.6× 71 0.6× 77 0.7× 27 0.5× 41 647

Countries citing papers authored by Burton Needles

Since Specialization
Citations

This map shows the geographic impact of Burton Needles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burton Needles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burton Needles more than expected).

Fields of papers citing papers by Burton Needles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burton Needles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burton Needles. The network helps show where Burton Needles may publish in the future.

Co-authorship network of co-authors of Burton Needles

This figure shows the co-authorship network connecting the top 25 collaborators of Burton Needles. A scholar is included among the top collaborators of Burton Needles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burton Needles. Burton Needles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lee, Simon J. Craddock, Mark A. Clark, John V. Cox, et al.. (2016). Achieving Coordinated Care for Patients With Complex Cases of Cancer: A Multiteam System Approach. Journal of Oncology Practice. 12(11). 1029–1038. 41 indexed citations
2.
Rapp, Stephen R., Doug Case, Ann M. Peiffer, et al.. (2013). Phase III randomized, double-blind, placebo-controlled trial of donepezil in irradiated brain tumor survivors.. Journal of Clinical Oncology. 31(15_suppl). 2006–2006. 10 indexed citations
3.
Cohen, Ezra E.W., Burton Needles, Stuart J. Wong, et al.. (2008). Phase 2 study of sunitinib in refractory thyroid cancer. Journal of Clinical Oncology. 26(15_suppl). 6025–6025. 118 indexed citations
4.
Hirsh, Vera, P. Desjardins, Burton Needles, et al.. (2007). Oral Versus Intravenous Administration of Vinorelbine as a Single Agent for the First-Line Treatment of Metastatic Nonsmall Cell Lung Carcinoma (NSCLC). American Journal of Clinical Oncology. 30(3). 245–251. 14 indexed citations
5.
Land, Stephanie R., Jacek A Kopec, Reena S. Cecchini, et al.. (2007). Neurotoxicity From Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: NSABP C-07. Journal of Clinical Oncology. 25(16). 2205–2211. 184 indexed citations
6.
Dunphy, Frank, Bruce R. Harrison, Kathryn Trinkaus, et al.. (2001). Induction paclitaxel and carboplatin for patients with head and neck carcinoma. Cancer. 91(5). 940–948. 33 indexed citations
7.
Schroder, Louis E., Danika L. Lew, Robert C. Flanigan, et al.. (2001). Phase II evaluation of suramin in advanced renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 6(4). 145–148. 2 indexed citations
8.
Dunphy, Frank, Bruce R. Harrison, Kathryn Trinkaus, et al.. (2001). Induction paclitaxel and carboplatin for patients with head and neck carcinoma. Cancer. 91(5). 940–948. 6 indexed citations
9.
Needles, Burton, Eduardo Miranda, Jesse I. Spector, et al.. (1999). A multicenter, double-blind, randomized comparison of oral ondansetron 8 mg b.i.d., 24 mg q.d., and 32 mg q.d. in the prevention of nausea and vomiting associated with highly emetogenic chemotherapy. Supportive Care in Cancer. 7(5). 347–353. 7 indexed citations
10.
Adkins, Douglas, Robert W. Brown, Richard T. Maziarz, et al.. (1999). Outcomes of High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in Stage IIIB Inflammatory Breast Cancer. Journal of Clinical Oncology. 17(7). 2006–2006. 29 indexed citations
11.
Ahmed, Tauseef, Alan Yagoda, Burton Needles, et al.. (1985). Vinblastine and Methotrexate for Advanced Bladder Cancer. The Journal of Urology. 133(4). 602–604. 26 indexed citations
12.
Needles, Burton, Alan Yagoda, Pramod C. Sogani, Harry Grabstald, & Willet F. Whitmore. (1983). Intravenous Cisplatin for Superficial Bladder Tumors. The Journal of Urology. 129(6). 1280–1280.
13.
Benedetto, Pasquale, Tauseef Ahmed, Burton Needles, Robin C. Watson, & Alan Yagoda. (1983). Phase II trial of 4ʼepi-adriamycin for advanced hypernephroma. American Journal of Clinical Oncology. 6(5). 553–554. 7 indexed citations
14.
Benedetto, Pasquale, Tauseef Ahmed, Burton Needles, Robin C. Watson, & Alan Yagoda. (1983). Phase II trial of 4ʼepi-adriamycin for advanced hypernephroma. American Journal of Clinical Oncology. 6(5). 553–554. 7 indexed citations
15.
Blumenreich, Martin S., Burton Needles, Alan Yagoda, et al.. (1982). Intravesical cisplatin for superficial bladder tumors. Cancer. 50(5). 863–865. 27 indexed citations
16.
Needles, Burton, Alan Yagoda, Pramod C. Sogani, Harry Grabstald, & Willet F. Whitmore. (1982). Intravenous cisplatin for superficial bladder tumors. Cancer. 50(9). 1722–1723. 6 indexed citations
17.
Needles, Burton, Nancy Kemeny, & Carlos Urmacher. (1981). Malignant thymoma: Renal metastases responding to cis-platinum. Cancer. 48(2). 223–226. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026